Pa ALS Protocol Review I

Atropine for bradycardia

Epinephrine in cardiac arrest

Ondansetron for nausea

Adenosine for symptomatic atrial flutter

4

5

6

7

8

Sinus bradycardia with a first degree heart block

Junctional rhythm

Sinus tachycardia with occasional ectopy

Third degree AV block

Epinephrine, 5 mL, 1:1000

Albuterol, 2.5 mg

Terbutaline, 0.25 mg

Ipratropium Bromide, 500 mcg

Allergic reaction

Burns

Systemic inflammatory response syndrome

Narrow complex tachycardia

Ondansetron and Lorazepam is one combination of drugs that could be given to a patient complaining of both severe nausea and severe vertigo.

You can administer as much as 2 mg naloxone to a hypoglycemic patient whose altered mental status is refractory to 25 g of 50% dextrose.

Standing orders permit administering narcotic analgesics to patients complaining of left lower flank pain associated with extensive renal calculus.

You may proceed directly to administering a benzodiazepine drug to an actively seizing patient if that patient is known to have a history of seizures.

Patient must be at least 3 months of age.

The patient’s temperature must exceed 100.4 degrees Fahrenheit.

The patient has not had a dose of acetaminophen within the last 4 hours.

Acetaminophen cannot be taken in conjunction with aspirin or other NSAIDs.

4 mg ondansetron

400 mg acetaminophen

400 mL bolus of normal saline solution

40% oxygen delivered via simple face mask in blow-by configuration

10 mL of D50 mixed with 40 mL normal saline solution

10 mL of D50 mixed with 40 mL D5W

20 mL of D50 mixed with 80 mL normal saline solution

10 mL of D50 mixed with 90 mL normal saline solution

Epinephrine

Glucagon

Lorazepam

Fentanyl Citrate

Morphine Sulfate

Midazolam

Furosemide

Ondansetron

20 mcg/kg/min of dobutamine for treatment of cardiogenic shock secondary to CHF

0.1 mg/kg of midazolam for treatment of seizures

35 mcg/min of epinephrine for treatment of bradycardia

5 mL/kg of D10 to a pediatric patient with glucose of 42 mg/dL

Unstable atrial flutter

Unstable atrial fibrillation

Unstable ventricular tachycardia

Unstable pulsed ventricular fibrillation

7 mcg/min

7.5 mcg/min titrated upward until a systolic blood pressure of at least 100 mmHg is achieved

0.1 – 0.5 mcg/kg/min titrated until SBP > 90 mmHg

Begin at 7.5 mcg/min and increase slowly until either SBP > 90 mmHg or until a maximum dose of 10 mcg/min

Patient with a heart rate of 45, altered mental status attributable to cardiac output, blood pressure of 102/40, prior to pacing.

Patient in an active, focal seizure in her legs who is conscious, alert, and oriented.

Patient complaining of severe vertigo.

Unrestrained agitated behavioral patient with no underlying medical conditions who continues to struggle despite attempts to use verbal techniques.

Diltiazem, 0.25 mg/kg, for treatment of an regular narrow complex tachycardia in an adult patient

Adenosine, 0.1 mg/kg, for treatment of stable SVT in a pediatric patient

Lidocaine, 1.5 mg/kg, for treatment of a regular wide QRS rhythm in an adult patient

Amiodorone, 150 mg, for treatment of an irregular wide complex tachycardia in an adult patient